Skip to main content
Erschienen in: Supportive Care in Cancer 6/2020

15.11.2019 | Original Article

Relationships among body composition, muscle strength, and sarcopenia in esophageal squamous cell carcinoma patients

verfasst von: Kotaro Sugawara, Hiroharu Yamashita, Yasuhiro Okumura, Koichi Yagi, Shuntaro Yoshimura, Koichiro Kawasaki, Asami Tanabe, Susumu Aikou, Yasuyuki Seto

Erschienen in: Supportive Care in Cancer | Ausgabe 6/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Relationships among body composition indices assessed by various modalities remain to be addressed in patients with esophageal squamous cell carcinoma (ESCC), in whom being underweight is more strikingly prevalent than in those with other malignancies. We investigated the relationships of body composition parameters with the sarcopenia prevalence of ESCC patients.

Methods

In this prospective study, we analyzed preoperative data obtained from 75 ESCC patients undergoing esophagectomy. Body composition data included body mass index (BMI), skeletal muscle index (SMI) assessed by computed tomography, and parameters calculated by bioelectrical impedance analysis (skeletal muscle mass (SMM), body fat mass). Muscle strength was evaluated by handgrip strength (HGS). Sarcopenia was defined as having both low SMI and low HGS.

Results

The median BMI value was 22.5 (range 15.2–28.7) in our ESCC cohort. BMI correlated significantly with fat mass (r = 0.84, P < 0.001), SMM (r = 0.57, P < 0.001) and SMI (r = 0.49, P < 0.001). Similarly, SMI showed a significant correlation with SMM (r = 0.45, P < 0.001). Meanwhile, HGS was highly correlated with SMM (r = 0.67, P < 0.001), while showing significant but weak associations with both BMI and SMI (r = 0.33, 0.34, respectively, P < 0.001). Notably, sarcopenia prevalence differed markedly according to BMI category; 28.6%, 12.2%, and 0% in the low (< 20), medium (20–25), and high (> 25) BMI groups, respectively.

Conclusions

BMI reflects comprehensive information on body composition in ESCC patients, although its correlation with muscle mass and muscle strength was moderate. Decreased BMI might serve as an indicator for sarcopenia in this population, in which the presence of sarcopenic obesity is rare.
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Jemal A, Cancer statistics (2015) CA Cancer J Clin 65:5–29CrossRef Siegel RL, Miller KD, Jemal A, Cancer statistics (2015) CA Cancer J Clin 65:5–29CrossRef
2.
Zurück zum Zitat Lagergren J, Smyth E, Cunningham D, Lagergren P (2017) Oesophageal cancer. Lancet (London, England) 390:2383–2396CrossRef Lagergren J, Smyth E, Cunningham D, Lagergren P (2017) Oesophageal cancer. Lancet (London, England) 390:2383–2396CrossRef
3.
Zurück zum Zitat Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335:1134CrossRef Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D (2007) Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 335:1134CrossRef
4.
Zurück zum Zitat Smith M, Zhou M, Whitlock G, Yang G, Offer A, Hui G, Peto R, Huang Z, Chen Z (2008) Esophageal cancer and body mass index: results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int J Cancer 122:1604–1610CrossRef Smith M, Zhou M, Whitlock G, Yang G, Offer A, Hui G, Peto R, Huang Z, Chen Z (2008) Esophageal cancer and body mass index: results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int J Cancer 122:1604–1610CrossRef
5.
Zurück zum Zitat Lahmann PH, Pandeya N, Webb PM, Green AC, Whiteman DC (2012) Body mass index, long-term weight change, and esophageal squamous cell carcinoma: is the inverse association modified by smoking status? Cancer. 118:1901–1909CrossRef Lahmann PH, Pandeya N, Webb PM, Green AC, Whiteman DC (2012) Body mass index, long-term weight change, and esophageal squamous cell carcinoma: is the inverse association modified by smoking status? Cancer. 118:1901–1909CrossRef
6.
Zurück zum Zitat Boshier PR, Heneghan R, Markar SR, Baracos VE, Low DE (2018) Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis. Dis Esophagus 31 Boshier PR, Heneghan R, Markar SR, Baracos VE, Low DE (2018) Assessment of body composition and sarcopenia in patients with esophageal cancer: a systematic review and meta-analysis. Dis Esophagus 31
7.
Zurück zum Zitat McQuade JL, Daniel CR, Hess KR, Mak C, Wang DY, Rai RR, Park JJ, Haydu LE, Spencer C, Wongchenko M, Lane S, Lee DY, Kaper M, McKean M, Beckermann KE, Rubinstein SM, Rooney I, Musib L, Budha N, Hsu J, Nowicki TS, Avila A, Haas T, Puligandla M, Lee S, Fang S, Wargo JA, Gershenwald JE, Lee JE, Hwu P, Chapman PB, Sosman JA, Schadendorf D, Grob JJ, Flaherty KT, Walker D, Yan Y, McKenna E, Legos JJ, Carlino MS, Ribas A, Kirkwood JM, Long GV, Johnson DB, Menzies AM, Davies MA (2018) Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Lancet Oncol 19:310–322CrossRef McQuade JL, Daniel CR, Hess KR, Mak C, Wang DY, Rai RR, Park JJ, Haydu LE, Spencer C, Wongchenko M, Lane S, Lee DY, Kaper M, McKean M, Beckermann KE, Rubinstein SM, Rooney I, Musib L, Budha N, Hsu J, Nowicki TS, Avila A, Haas T, Puligandla M, Lee S, Fang S, Wargo JA, Gershenwald JE, Lee JE, Hwu P, Chapman PB, Sosman JA, Schadendorf D, Grob JJ, Flaherty KT, Walker D, Yan Y, McKenna E, Legos JJ, Carlino MS, Ribas A, Kirkwood JM, Long GV, Johnson DB, Menzies AM, Davies MA (2018) Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis. Lancet Oncol 19:310–322CrossRef
8.
Zurück zum Zitat Sepesi B, Gold KA, Correa AM, Heymach JV, Vaporciyan AA, Roszik J et al (2017) The influence of body mass index on overall survival following surgical resection of non-small cell lung cancer. J Thorac Oncol 12:1280–1287CrossRef Sepesi B, Gold KA, Correa AM, Heymach JV, Vaporciyan AA, Roszik J et al (2017) The influence of body mass index on overall survival following surgical resection of non-small cell lung cancer. J Thorac Oncol 12:1280–1287CrossRef
9.
Zurück zum Zitat Ji W, Zheng W, Li B, Cao C, Mao W (2016) Influence of body mass index on the long-term outcomes of patients with esophageal squamous cell carcinoma who underwent esophagectomy as a primary treatment: a 10-year medical experience. Medicine 95:e4204CrossRef Ji W, Zheng W, Li B, Cao C, Mao W (2016) Influence of body mass index on the long-term outcomes of patients with esophageal squamous cell carcinoma who underwent esophagectomy as a primary treatment: a 10-year medical experience. Medicine 95:e4204CrossRef
10.
Zurück zum Zitat Watanabe M, Ishimoto T, Baba Y, Nagai Y, Yoshida N, Yamanaka T, Baba H (2013) Prognostic impact of body mass index in patients with squamous cell carcinoma of the esophagus. Ann Surg Oncol 20:3984–3991CrossRef Watanabe M, Ishimoto T, Baba Y, Nagai Y, Yoshida N, Yamanaka T, Baba H (2013) Prognostic impact of body mass index in patients with squamous cell carcinoma of the esophagus. Ann Surg Oncol 20:3984–3991CrossRef
11.
Zurück zum Zitat Zhang SS, Yang H, Luo KJ, Huang QY, Chen JY, Yang F, Cai XL, Xie X, Liu QW, Bella AE, Hu RG, Wen J, Hu Y, Fu JH (2013) The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis. Br J Cancer 109:2894–2903CrossRef Zhang SS, Yang H, Luo KJ, Huang QY, Chen JY, Yang F, Cai XL, Xie X, Liu QW, Bella AE, Hu RG, Wen J, Hu Y, Fu JH (2013) The impact of body mass index on complication and survival in resected oesophageal cancer: a clinical-based cohort and meta-analysis. Br J Cancer 109:2894–2903CrossRef
12.
Zurück zum Zitat Brown JC, Cespedes Feliciano EM, Caan BJ (2018) The evolution of body composition in oncology-epidemiology, clinical trials, and the future of patient care: facts and numbers. J Cachexia Sarcopenia Muscle 9:1200–1208CrossRef Brown JC, Cespedes Feliciano EM, Caan BJ (2018) The evolution of body composition in oncology-epidemiology, clinical trials, and the future of patient care: facts and numbers. J Cachexia Sarcopenia Muscle 9:1200–1208CrossRef
13.
Zurück zum Zitat Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629–635CrossRef Prado CM, Lieffers JR, McCargar LJ, Reiman T, Sawyer MB, Martin L, Baracos VE (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: a population-based study. Lancet Oncol 9:629–635CrossRef
14.
Zurück zum Zitat Baracos VE, Arribas L (2018) Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol 29:ii1–ii9CrossRef Baracos VE, Arribas L (2018) Sarcopenic obesity: hidden muscle wasting and its impact for survival and complications of cancer therapy. Ann Oncol 29:ii1–ii9CrossRef
15.
Zurück zum Zitat Ceniccola GD, Castro MG, Piovacari SMF, Horie LM, Correa FG, Barrere APN et al (2019) Current technologies in body composition assessment: advantages and disadvantages. Nutrition 62:25–31CrossRef Ceniccola GD, Castro MG, Piovacari SMF, Horie LM, Correa FG, Barrere APN et al (2019) Current technologies in body composition assessment: advantages and disadvantages. Nutrition 62:25–31CrossRef
16.
Zurück zum Zitat Heymsfield SB, Adamek M, Gonzalez MC, Jia G, Thomas DM (2014) Assessing skeletal muscle mass: historical overview and state of the art. J Cachexia Sarcopenia Muscle 5:9–18CrossRef Heymsfield SB, Adamek M, Gonzalez MC, Jia G, Thomas DM (2014) Assessing skeletal muscle mass: historical overview and state of the art. J Cachexia Sarcopenia Muscle 5:9–18CrossRef
17.
Zurück zum Zitat Elliott JA, Doyle SL, Murphy CF, King S, Guinan EM, Beddy P et al (2017) Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg 266:822–830CrossRef Elliott JA, Doyle SL, Murphy CF, King S, Guinan EM, Beddy P et al (2017) Sarcopenia: prevalence, and impact on operative and oncologic outcomes in the multimodal management of locally advanced esophageal cancer. Ann Surg 266:822–830CrossRef
18.
Zurück zum Zitat Nakashima Y, Saeki H, Nakanishi R, Sugiyama M, Kurashige J, Oki E, Maehara Y (2018) Assessment of sarcopenia as a predictor of poor outcomes after esophagectomy in elderly patients with esophageal cancer. Ann Surg 267:1100–1104CrossRef Nakashima Y, Saeki H, Nakanishi R, Sugiyama M, Kurashige J, Oki E, Maehara Y (2018) Assessment of sarcopenia as a predictor of poor outcomes after esophagectomy in elderly patients with esophageal cancer. Ann Surg 267:1100–1104CrossRef
19.
Zurück zum Zitat Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39:412–423CrossRef Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M, European Working Group on Sarcopenia in Older People (2010) Sarcopenia: European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people. Age Ageing 39:412–423CrossRef
20.
Zurück zum Zitat Lee SY, Ahn S. Comparison between dual-energy X-ray absorptiometry and bioelectrical impedance analyses for accuracy in mseasuring whole body muscle mass and appendicular skeletal muscle mass. 2018;10 Lee SY, Ahn S. Comparison between dual-energy X-ray absorptiometry and bioelectrical impedance analyses for accuracy in mseasuring whole body muscle mass and appendicular skeletal muscle mass. 2018;10
21.
Zurück zum Zitat Goodman MJ, Ghate SR, Mavros P, Sen S, Marcus RL, Joy E et al (2013) Development of a practical screening tool to predict low muscle mass using NHANES 1999-2004. J Cachexia Sarcopenia Muscle 4:187–197CrossRef Goodman MJ, Ghate SR, Mavros P, Sen S, Marcus RL, Joy E et al (2013) Development of a practical screening tool to predict low muscle mass using NHANES 1999-2004. J Cachexia Sarcopenia Muscle 4:187–197CrossRef
22.
Zurück zum Zitat Cresta Morgado P, Daud M, Carballido M, Mendez G, Iseas S, Lobbe V et al (2019) Relationship between skeletal muscle function, body composition, and weight loss in patients with advanced pancreatic and gastrointestinal cancers. Support Care Cancer 27:1181–1186CrossRef Cresta Morgado P, Daud M, Carballido M, Mendez G, Iseas S, Lobbe V et al (2019) Relationship between skeletal muscle function, body composition, and weight loss in patients with advanced pancreatic and gastrointestinal cancers. Support Care Cancer 27:1181–1186CrossRef
23.
Zurück zum Zitat Sugawara K, Yoshimura S, Yagi K, Nishida M, Aikou S, Yamagata Y et al (2019) Long-term health-related quality of life following robot-assisted radical transmediastinal esophagectomy. Surg Endosc Sugawara K, Yoshimura S, Yagi K, Nishida M, Aikou S, Yamagata Y et al (2019) Long-term health-related quality of life following robot-assisted radical transmediastinal esophagectomy. Surg Endosc
24.
Zurück zum Zitat Rice TW, Blackstone EH, Rusch VW (2010) 7th edition of the AJCC Cancer staging manual: esophagus and esophagogastric junction. Ann Surg Oncol 17:1721–1724CrossRef Rice TW, Blackstone EH, Rusch VW (2010) 7th edition of the AJCC Cancer staging manual: esophagus and esophagogastric junction. Ann Surg Oncol 17:1721–1724CrossRef
25.
Zurück zum Zitat Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A et al (2003) Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95:1851–1860CrossRef Lauretani F, Russo CR, Bandinelli S, Bartali B, Cavazzini C, Di Iorio A et al (2003) Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 95:1851–1860CrossRef
26.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRef Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376CrossRef
27.
Zurück zum Zitat Blazeby JM, Conroy T, Hammerlid E, Fayers P, Sezer O, Koller M et al (2003) Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 39:1384–1394CrossRef Blazeby JM, Conroy T, Hammerlid E, Fayers P, Sezer O, Koller M et al (2003) Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer. Eur J Cancer 39:1384–1394CrossRef
28.
Zurück zum Zitat Fayers P, Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. 2001 EORTC QLQ-C30 Scoring Manual. (3rd ed.) Brussels: European Organisation for Research and Treatment of Cancer Fayers P, Aaronson, N. K., Bjordal, K., Groenvold, M., Curran, D., & Bottomley, A. 2001 EORTC QLQ-C30 Scoring Manual. (3rd ed.) Brussels: European Organisation for Research and Treatment of Cancer
29.
Zurück zum Zitat Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB, Baracos VE (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539–1547CrossRef Martin L, Birdsell L, Macdonald N, Reiman T, Clandinin MT, McCargar LJ, Murphy R, Ghosh S, Sawyer MB, Baracos VE (2013) Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index. J Clin Oncol 31:1539–1547CrossRef
30.
Zurück zum Zitat Dijksterhuis WPM, Pruijt MJ, van der Woude SO, Klaassen R, Kurk SA, van Oijen MGH et al (2019) Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy. J Cachexia Sarcopenia Muscle 10:199–206CrossRef Dijksterhuis WPM, Pruijt MJ, van der Woude SO, Klaassen R, Kurk SA, van Oijen MGH et al (2019) Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy. J Cachexia Sarcopenia Muscle 10:199–206CrossRef
31.
Zurück zum Zitat Yamada Y, Yoshida T, Yokoyama K, Watanabe Y, Miyake M, Yamagata E et al (2017) The extracellular to intracellular water ratio in upper legs is negatively associated with skeletal muscle strength and gait speed in older people. J Gerontol A Biol Sci Med Sci 72:293–298CrossRef Yamada Y, Yoshida T, Yokoyama K, Watanabe Y, Miyake M, Yamagata E et al (2017) The extracellular to intracellular water ratio in upper legs is negatively associated with skeletal muscle strength and gait speed in older people. J Gerontol A Biol Sci Med Sci 72:293–298CrossRef
32.
Zurück zum Zitat Grundmann O, Yoon SL, Williams JJ (2015) The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients--a comprehensive review. Eur J Clin Nutr 69:1290–1297CrossRef Grundmann O, Yoon SL, Williams JJ (2015) The value of bioelectrical impedance analysis and phase angle in the evaluation of malnutrition and quality of life in cancer patients--a comprehensive review. Eur J Clin Nutr 69:1290–1297CrossRef
33.
Zurück zum Zitat Byun SS, Hwang EC, Kang SH, Hong SH, Chung J, Kwon TG et al (2018) Age-dependent prognostic value of body mass index for non-metastatic clear cell renal cell carcinoma: a large multicenter retrospective analysis. J Surg Oncol 118:199–205CrossRef Byun SS, Hwang EC, Kang SH, Hong SH, Chung J, Kwon TG et al (2018) Age-dependent prognostic value of body mass index for non-metastatic clear cell renal cell carcinoma: a large multicenter retrospective analysis. J Surg Oncol 118:199–205CrossRef
34.
Zurück zum Zitat Zheng W, McLerran DF, Rolland B, Zhang X, Inoue M, Matsuo K, He J, Gupta PC, Ramadas K, Tsugane S, Irie F, Tamakoshi A, Gao YT, Wang R, Shu XO, Tsuji I, Kuriyama S, Tanaka H, Satoh H, Chen CJ, Yuan JM, Yoo KY, Ahsan H, Pan WH, Gu D, Pednekar MS, Sauvaget C, Sasazuki S, Sairenchi T, Yang G, Xiang YB, Nagai M, Suzuki T, Nishino Y, You SL, Koh WP, Park SK, Chen Y, Shen CY, Thornquist M, Feng Z, Kang D, Boffetta P, Potter JD (2011) Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med 364:719–729CrossRef Zheng W, McLerran DF, Rolland B, Zhang X, Inoue M, Matsuo K, He J, Gupta PC, Ramadas K, Tsugane S, Irie F, Tamakoshi A, Gao YT, Wang R, Shu XO, Tsuji I, Kuriyama S, Tanaka H, Satoh H, Chen CJ, Yuan JM, Yoo KY, Ahsan H, Pan WH, Gu D, Pednekar MS, Sauvaget C, Sasazuki S, Sairenchi T, Yang G, Xiang YB, Nagai M, Suzuki T, Nishino Y, You SL, Koh WP, Park SK, Chen Y, Shen CY, Thornquist M, Feng Z, Kang D, Boffetta P, Potter JD (2011) Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med 364:719–729CrossRef
35.
Zurück zum Zitat Minematsu A, Hazaki K, Harano A, Okamoto N, Kurumatani N (2016) Differences in physical function by body mass index in elderly Japanese individuals: the Fujiwara-kyo Study. Obes Res Clin Pract 10:41–48CrossRef Minematsu A, Hazaki K, Harano A, Okamoto N, Kurumatani N (2016) Differences in physical function by body mass index in elderly Japanese individuals: the Fujiwara-kyo Study. Obes Res Clin Pract 10:41–48CrossRef
36.
Zurück zum Zitat Woo J, Leung J, Kwok T (2007) BMI, body composition, and physical functioning in older adults. Obesity (Silver Spring, Md) 15:1886–1894CrossRef Woo J, Leung J, Kwok T (2007) BMI, body composition, and physical functioning in older adults. Obesity (Silver Spring, Md) 15:1886–1894CrossRef
37.
Zurück zum Zitat Bye A, Sjoblom B, Wentzel-Larsen T, Gronberg BH, Baracos VE, Hjermstad MJ et al (2017) Muscle mass and association to quality of life in non-small cell lung cancer patients. J Cachexia Sarcopenia Muscle 8:759–767CrossRef Bye A, Sjoblom B, Wentzel-Larsen T, Gronberg BH, Baracos VE, Hjermstad MJ et al (2017) Muscle mass and association to quality of life in non-small cell lung cancer patients. J Cachexia Sarcopenia Muscle 8:759–767CrossRef
38.
Zurück zum Zitat Guinan EM, Doyle SL, Bennett AE, O’Neill L, Gannon J, Elliott JA, O'Sullivan J, Reynolds JV, Hussey J (2018) Sarcopenia during neoadjuvant therapy for oesophageal cancer: characterising the impact on muscle strength and physical performance. Supportive Care Cancer 26:1569–1576 Guinan EM, Doyle SL, Bennett AE, O’Neill L, Gannon J, Elliott JA, O'Sullivan J, Reynolds JV, Hussey J (2018) Sarcopenia during neoadjuvant therapy for oesophageal cancer: characterising the impact on muscle strength and physical performance. Supportive Care Cancer 26:1569–1576
39.
Zurück zum Zitat Ida S, Watanabe M, Karashima R, Imamura Y, Ishimoto T, Baba Y, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Baba H (2014) Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy. Ann Surg Oncol 21:3675–3679CrossRef Ida S, Watanabe M, Karashima R, Imamura Y, Ishimoto T, Baba Y, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Baba H (2014) Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy. Ann Surg Oncol 21:3675–3679CrossRef
Metadaten
Titel
Relationships among body composition, muscle strength, and sarcopenia in esophageal squamous cell carcinoma patients
verfasst von
Kotaro Sugawara
Hiroharu Yamashita
Yasuhiro Okumura
Koichi Yagi
Shuntaro Yoshimura
Koichiro Kawasaki
Asami Tanabe
Susumu Aikou
Yasuyuki Seto
Publikationsdatum
15.11.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 6/2020
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-019-05110-7

Weitere Artikel der Ausgabe 6/2020

Supportive Care in Cancer 6/2020 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.